The world was not lying behind the hydroxychloroquine drug. This medicine really has power. Till now studies done in foreign countries used to claim this, but now this has also been confirmed in studies done in AIIMS. According to the Indian Council of Medical Research (ICMR), a specific dose of this medicine is benefiting Corona patients.
The government also claimed that corona infection was seen among the health workers who were given this medicine. So far 100 countries have taken this medicine from India. It has now been recommended by the Ministry of Health to give this medicine to other personnel also involved in the rescue of COVID. Till now, this medicine was being given only to people exposed to COVID patients and health workers.
A study was done at AIIMS:
This study was done on 334 health workers in AIIMS, New Delhi. Of these, 248 were given hydroxychloroquine, the rest not. After six weeks it was found that those who were being given medication had fewer cases of corona infection. More in the second group. After this study, the ICMR considered it to be dominant in defence.
Advice to security personnel:
New guidelines have also been issued by the Ministry of Health regarding the use of hydroxychloroquine. It has been recommended to give this medicine to policemen, paramilitary forces and others posted in the Containment Zone. The Health Ministry has also rescheduled the dose afresh.
Recommendation not to give to children:
the third result has been concluded that it is also causing side effects. It is recommended not to give medicines to heart patients, pregnant women, people with retinal diseases and children younger than 15 years.
Side effects: A
Variety of side effects were seen in 1323 health workers who were being given this medicine in three hospitals including AIIMS. 9.8% had nausea, 7.3% had abdominal pain, 1.5% had vomiting, 1.7 had hypoglycemia and 1.9% had cardiovascular problems. Therefore, the guidelines state that it should not be taken without a doctor’s advice. It has also been clarified that chloroquine rescue is not fully guaranteed.
Dr. Jugal Kishore, director of community medicine department of Vardhman Mahaveer Medical College, says that studies on hydroxychloroquine should be published with inclusion in the guideline. This needs further study.